Rectal Cancer
Rectal cancer is a type of cancer that develops in the rectum, the last part of the large intestine, often leading to symptoms like rectal bleeding, changes in bowel habits, and abdominal discomfort.
Rectal Cancer: Ferumoxtran-10 MRI Study
We are testing a new MRI method to see if it better identifies lymph node involvement in patients with newly diagnosed rectal cancer. This may help doctors plan more effective treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Mesorectal Lymph Node Metastases
Mesorectal lymph node metastases occur when cancer cells spread from the rectum to the lymph nodes in the mesorectum, which can complicate treatment and may lead to symptoms related to the primary cancer.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have newly diagnosed rectal cancer?
- Are you currently pregnant or breastfeeding?
- Do you have a history of severe allergic reactions to iron products?
- Have you had prior abdominopelvic radiation?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Varsinais-Suomen hyvinvointialue
Radiology
Turku, Finland
Sponsor: Varsinais-Suomen hyvinvointialue
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.